The Glow Blend is a compounded peptide formulation (BPC-157, GHK-Cu, KPV, TB-500) that may be discussed with eligible patients as part of a personalized care plan. Whether this option is appropriate is determined by a licensed provider during consultation.
About this formulation
This blend contains multiple compounded peptides. Compounded peptides are not FDA-approved. Compounded medications are prepared by a state-licensed compounding pharmacy. Suitability is determined by a licensed provider after reviewing your medical history.
What your provider may discuss during consultation
- Whether this option may align with your individual goals
- Mechanism of the included peptides (educational only — not a benefit claim)
- Risks, side effects, contraindications, and alternatives
- Monitoring expectations and follow-up
Individual response varies. No physiological outcome is guaranteed. We do not market this product as a treatment for chronic pain, inflammation, post-surgical recovery, or any specific medical condition.
How treatment is initiated
A licensed provider conducts a one-on-one telemedicine consultation, reviews your medical history, and determines whether this option is appropriate. Self-administration technique, if applicable, is taught by the provider after that determination is made.
Frequently asked questions
Who is a candidate?
Candidate suitability is determined by a licensed provider after consultation. This option is not appropriate for minors, pregnant or breastfeeding patients, or anyone with certain underlying conditions identified during consultation.
What are the risks?
Compounded peptides are not FDA-approved. Individual risks vary and should be discussed with a licensed provider. Side effects can include injection-site reactions and others reviewed during consultation.
Important Information About Peptide Therapy
Peptides discussed on this page are not FDA-approved. Any compounded peptide formulation dispensed through IV Glow Bar comes from a state-licensed compounding pharmacy and is not FDA-approved.
Eligibility is determined by a licensed provider after a comprehensive consultation. Peptide therapy is not appropriate for everyone — including minors, pregnant or breastfeeding patients, and patients with certain medical histories reviewed during consultation.
Mechanism descriptions on this page are educational only and are not benefit claims. Individual response varies, and we do not promise specific outcomes, timelines, or results.
Reporting Adverse Events. If you experience a side effect, contact us, your prescribing provider, and FDA MedWatch at https://www.fda.gov/safety/medwatch.
Emergencies. This site and our telehealth services are not for medical emergencies. Call 911 in a medical emergency.
